Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitors

por Weber, F, Fukino, K, Sawada, T, Williams, N, Sweet, K, Brena, R M, Plass, C, Caldes, T, Mutter, G L, Villalona-Calero, M A, Eng, C
Publicado 2005

A study of cancer risks in relatives of patients with serrated polyposis

por Win, AK, Walters, RJ, Buchanan, DD, Jenkins, MA, Sweet, K, McKeone, DM, Walsh, MD, Clendenning, M, Pearson, SA, Pavluk, E, Nagler, B, Hopper, JL, Walker, N, Rosty, C, Parry, S, Young, JP
Publicado 2012

PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMGN632) IN PATIENTS WITH UNTREATED/FRONTLINE BPDCN

por Pemmaraju, N., Martinelli, G., Todisco, E., Tarella, C., Montesinos, P., Lane, A. A., Erba, H. P., Sweet, K. L., Walter, R. B., Deconinck, E., Wang, E. S., Aribi, A., Ulrikson, M. L., Levy, M. Y., Lebon, D., Marconi, G., DeAngelo, D. J., Rizzieri, D., Konopleva, M., Sloss, C. M., Wang, J., Malcolm, K. A., Zweidler-McKay, P. A., Daver, N. G.
Publicado 2022